Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
American Journal of Hematology|September 16, 2022
Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patientsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Bone Marrow Transplantation|February 14, 2018
Stem cell transplantation for T-cell lymphomas in TaiwanYa-Ting Hsu, Hui-Jen Tsai, Jeffrey S Chang, et al.
Plos One|September 18, 2015
Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective StudyShang-Yi Huang, Hsiu-Hsia Lin, Ming Yao, et al.
Annals of Hematology|February 19, 2013
Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence--clinical implication and comparison between the West and the EastShang-Ju Wu, Chien-Ting Lin, Sheng-Yi Huang, et al.
British Journal of Haematology|September 19, 2006
Clinical implications of SOCS1 methylation in myelodysplastic syndromeShang-Ju Wu, Ming Yao, Wen-Chien Chou, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 20, 2004
Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancyChien-Yuan Chen, Jih-Luh Tang, Po-Ren Hsueh, et al.
Plos One|April 12, 2013
Clinical and microbiological characteristics of perianal infections in adult patients with acute leukemiaChien-Yuan Chen, Aristine Cheng, Shang-Yi Huang, et al.
Annals of Hematology|April 2, 2014
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myelomaShang-Yi Huang, Chung-Wu Lin, Hsiu-Hsia Lin, et al.
Cancer Research|March 17, 2006
Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolutionWen-Chien Chou, Jih-Luh Tang, Liang-In Lin, et al.
Annals of Hematology|January 23, 2020
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclaxYu-Wen Wang, Cheng-Hong Tsai, Chien-Chin Lin, et al.
Pageof 12